Simplex Trading, LLC Fennec Pharmaceuticals Inc. Transaction History

Simplex Trading, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$6.48 - $11.61 $77 - $139	12 New	12 $0
Q4 2022 Feb 02, 2023	BUY	$7.91 - $10.22 $23,105 - $29,852	2,921 New	2,921 $28,000
Q2 2022 Aug 03, 2022	BUY	$5.17 - $6.33 $11,255 - $13,780	2,177 New	2,177 $12,000
Q1 2022 May 02, 2022	SELL	$4.29 - $6.08 $3,856 - $5,465	-899 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$3.89 - $10.01 $2,559 - $6,586	658 Added 273.03%	899 $3,000

Q2 2021 Aug 12, 2021	SELL	$5.96 - $7.85 $5,036 - $6,633	-845 Reduced 77.81%	241 $1,000
Q1 2021 Apr 26, 2021	SELL	$6.21 - $8.68 $5,427 - $7,586	-874 Reduced 44.59%	1,086 $6,000
Q4 2020 Feb 02, 2021	BUY	$5.99 - $8.55 $11,099 - $15,843	1,853 Added 1731.78%	1,960 $14,000
Q3 2020 Oct 14, 2020	SELL	$5.19 - $10.17 $6,503 - $12,743	-1,253 Reduced 92.13%	107 $0
Q2 2020 Jul 13, 2020	BUY	$5.43 - $9.39 $7,384 - $12,770	1,360 New	1,360 $0
Q4 2019 Feb 05, 2020	SELL	$4.25 - $6.49 $425 - $649	-100 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$3.85 - $4.95 $385 - $495	100 New	100 $0

14.4M

53.2K

83.9K

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $157M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.